ELEVARA MEDICINES
HQ - London
Summary
Elevara Medicines, a clinical-stage biotech developing therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 52 M
Avg. Deal Size£ 52 M
All rights reserved. Copyright © 2025 Datasite
